The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Prospects for new antibiotics: a molecule-centered perspective
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's Sarcoma
Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M., & Moore, P. S. (1994) · Science · doi:10.1126/science.7997879 · Cited by 5,654
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Raetz, C. R. H., & Whitfield, C. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135414 · Cited by 4,404
Target-Oriented and Diversity-Oriented Organic Synthesis in Drug Discovery
Schreiber, S. L. (2000) · Science · doi:10.1126/science.287.5460.1964 · Cited by 2,568
Drugs for bad bugs: confronting the challenges of antibacterial discovery
Payne, D. J., Gwynn, M. N., Holmes, D. J., & Pompliano, D. L. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2201 · Cited by 2,512
A quantitative analysis of kinase inhibitor selectivity
Karaman, M. W., Herrgard, S., Treiber, D. K., Gallant, P., Atteridge, C. E., Campbell, B. T., Chan, K. W., Ciceri, P., Davis, M. I., Edeen, P. T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1358 · Cited by 2,466
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191
Protein kinases — the major drug targets of the twenty-first century?
Cohen, P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd773 · Cited by 2,186
Designing antimicrobial peptides: form follows function
Fjell, C. D., Hiss, J. A., Hancock, R. E. W., & Schneider, G. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3591 · Cited by 2,035
Antibiotics for Emerging Pathogens
Fischbach, M. A., & Walsh, C. T. (2009) · Science · doi:10.1126/science.1176667 · Cited by 1,777
Self-citationFalagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,744
The shared antibiotic resistome of soil bacteria and human pathogens
Forsberg, K. J., Reyes, A., Wang, B., Selleck, E. M., Sommer, M. O. A., & Dantas, G. (2012) · Science · doi:10.1126/science.1220761 · Cited by 1,650
Sampling the Antibiotic Resistome
D'Costa, V. M., McGrann, K. M., Hughes, D. W., & Wright, G. D. (2006) · Science · doi:10.1126/science.1120800 · Cited by 1,594
Structural Mechanism for Rifampicin Inhibition of Bacterial RNA Polymerase
Campbell, E. A., Korzheva, N., Mustaev, A., Murakami, K., Nair, S., Goldfarb, A., & Darst, S. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00286-0 · Cited by 1,556
Fischbach, M. A., & Walsh, C. T. (2006) · Chemical Reviews · doi:10.1021/cr0503097 · Cited by 1,464
Self-citationThe antibiotic resistome: the nexus of chemical and genetic diversity
Wright, G. D. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1614 · Cited by 1,365
Humans as the World's Greatest Evolutionary Force
Palumbi, S. R. (2001) · Science · doi:10.1126/science.293.5536.1786 · Cited by 1,290
Isolating "Uncultivable" Microorganisms in Pure Culture in a Simulated Natural Environment
Kaeberlein, T., Lewis, K., & Epstein, S. S. (2002) · Science · doi:10.1126/science.1070633 · Cited by 1,237
A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis
Stover, C. K., Warrener, P., VanDevanter, D. R., Sherman, D. R., Arain, T. M., Langhorne, M. H., Anderson, S. W., Towell, J. A., Yuan, Y., McMurray, D. N., et al. (2000) · Nature · doi:10.1038/35016103 · Cited by 1,034
Linezolid resistance in a clinical isolate of Staphylococcus aureus
Tsiodras, S., Gold, H. S., Sakoulas, G., Eliopoulos, G. M., Wennersten, C., Venkataraman, L., Moellering, R. C., & Ferraro, M. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05410-1 · Cited by 1,033
How many antibiotics are produced by the genus Streptomyces ?
Watve, M., Tickoo, R., Jog, M., & Bhole, B. (2001) · Archives of Microbiology · doi:10.1007/s002030100345 · Cited by 923
The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
Diacon, A. H., Pym, A., Grobusch, M., Patientia, R., Rustomjee, R., Page-Shipp, L., Pistorius, C., Krause, R., Bogoshi, M., Churchyard, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808427 · Cited by 835
Platensimycin is a selective FabF inhibitor with potent antibiotic properties
Wang, J., Soisson, S. M., Young, K., Shoop, W., Kodali, S., Galgoci, A., Painter, R., Parthasarathy, G., Tang, Y. S., Cummings, R., et al. (2006) · Nature · doi:10.1038/nature04784 · Cited by 812
Genetics and Assembly Line Enzymology of Siderophore Biosynthesis in Bacteria
Crosa, J. H., & Walsh, C. T. (2002) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.66.2.223-249.2002 · Cited by 797
Self-citationBenzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
Makarov, V., Manina, G., Mikusova, K., Möllmann, U., Ryabova, O., Saint-Joanis, B., Dhar, N., Pasca, M. R., Buroni, S., Lucarelli, A. P., et al. (2009) · Science · doi:10.1126/science.1171583 · Cited by 740
Fungal secondary metabolites – Strategies to activate silent gene clusters
Brakhage, A. A., & Schroeckh, V. (2011) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2010.04.004 · Cited by 729
Lipid II as a target for antibiotics
Breukink, E., & de Kruijff, B. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2004 · Cited by 701
Genetics and mechanisms of glycopeptide resistance in enterococci
Arthur, M., & Courvalin, P. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.8.1563 · Cited by 694
Glycopeptide and Lipoglycopeptide Antibiotics
Kahne, D., Leimkuhler, C., Lu, W., & Walsh, C. (2005) · Chemical Reviews · doi:10.1021/cr030103a · Cited by 662
Self-citationBugg, T. D. H., Wright, G. D., Dutka-Malen, S., Arthur, M., Courvalin, P., & Walsh, C. T. (1991) · Biochemistry · doi:10.1021/bi00107a007 · Cited by 650
Self-citationFtsZ in Bacterial Cytokinesis: Cytoskeleton and Force Generator All in One
Erickson, H. P., Anderson, D. E., & Osawa, M. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00021-10 · Cited by 638
Antibiotics: Actions, Origins, Resistance
Walsh, C. (2003) · Wiley eBooks · doi:10.1128/9781555817886 · Cited by 633
Self-citationPolyketide and Nonribosomal Peptide Antibiotics: Modularity and Versatility
Walsh, C. T. (2004) · Science · doi:10.1126/science.1094318 · Cited by 628
Self-citationNew antibiotics from bacterial natural products
Clardy, J., Fischbach, M. A., & Walsh, C. T. (2006) · Nature Biotechnology · doi:10.1038/nbt1266 · Cited by 615
Self-citationPeptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa
Srinivas, N., Jetter, P., Ueberbacher, B. J., Werneburg, M., Zerbe, K., Steinmann, J., Van der Meijden, B., Bernardini, F., Lederer, A., Dias, R. L. A., et al. (2010) · Science · doi:10.1126/science.1182749 · Cited by 554
Towards the Optimal Screening Collection: A Synthesis Strategy
Nielsen, T. E., & Schreiber, S. L. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200703073 · Cited by 551
Plectasin, a Fungal Defensin, Targets the Bacterial Cell Wall Precursor Lipid II
Schneider, T., Kruse, T., Wimmer, R., Wiedemann, I., Sass, V., Pag, U., Jansen, A., Nielsen, A. K., Mygind, P. H., Raventós, D. S., et al. (2010) · Science · doi:10.1126/science.1185723 · Cited by 550
Diarylquinolines target subunit c of mycobacterial ATP synthase
Koul, A., Dendouga, N., Vergauwen, K., Molenberghs, B., Vranckx, L., Willebrords, R., Ristic, Z., Lill, H., Dorange, I., Guillemont, J., et al. (2007) · Nature Chemical Biology · doi:10.1038/nchembio884 · Cited by 547
Hsu, S.-T. D., Breukink, E., Tischenko, E., Lutters, M. A. G., de Kruijff, B., Kaptein, R., Bonvin, A. M. J. J., & van Nuland, N. A. J. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb830 · Cited by 547
Avibactam is a covalent, reversible, non–β-lactam β-lactamase inhibitor
Ehmann, D. E., Jahić, H., Ross, P. L., Gu, R.-F., Hu, J., Kern, G., Walkup, G. K., & Fisher, S. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205073109 · Cited by 545
Dysregulation of bacterial proteolytic machinery by a new class of antibiotics
Brötz-Oesterhelt, H., Beyer, D., Kroll, H.-P., Endermann, R., Ladel, C., Schroeder, W., Hinzen, B., Raddatz, S., Paulsen, H., Henninger, K., et al. (2005) · Nature Medicine · doi:10.1038/nm1306 · Cited by 505
Natural Products Version 2.0: Connecting Genes to Molecules
Walsh, C. T., & Fischbach, M. A. (2010) · Journal of the American Chemical Society · doi:10.1021/ja909118a · Cited by 468
Self-citationSiderophores from Neighboring Organisms Promote the Growth of Uncultured Bacteria
D'Onofrio, A., Crawford, J. M., Stewart, E. J., Witt, K., Gavrish, E., Epstein, S., Clardy, J., & Lewis, K. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.02.010 · Cited by 453
An Inhibitor of FtsZ with Potent and Selective Anti-Staphylococcal Activity
Haydon, D. J., Stokes, N. R., Ure, R., Galbraith, G., Bennett, J. M., Brown, D. R., Baker, P. J., Barynin, V. V., Rice, D. W., Sedelnikova, S. E., et al. (2008) · Science · doi:10.1126/science.1159961 · Cited by 452
Paetzel, M., Karla, A., Strynadka, N. C. J., & Dalbey, R. E. (2002) · Chemical Reviews · doi:10.1021/cr010166y · Cited by 440
Aminoglycoside Antibiotics in the 21st Century
Becker, B., & Cooper, M. A. (2013) · ACS Chemical Biology · doi:10.1021/cb3005116 · Cited by 419
Bacterial resistance to vancomycin: five genes and one missing hydrogen bond tell the story
Walsh, C. T., Fisher, S. L., Park, I.-S., Prahalad, M., & Wu, Z. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90079-4 · Cited by 387
Self-citationStructure and Function of an Essential Component of the Outer Membrane Protein Assembly Machine
Kim, S., Malinverni, J. C., Sliz, P., Silhavy, T. J., Harrison, S. C., & Kahne, D. E. (2007) · Science · doi:10.1126/science.1143993 · Cited by 366
Vancomycin Assembly: Nature's Way
Hubbard, B. K., & Walsh, C. T. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200390202 · Cited by 356
Self-citationThe A-Z of bacterial translation inhibitors
Wilson, D. N. (2009) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409230903307311 · Cited by 322
Development of daptomycin for Gram-positive infections
Tally, F. P., & DeBruin, M. F. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.4.523 · Cited by 321
Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens
Brinster, S., Lamberet, G., Staels, B., Trieu-Cuot, P., Gruss, A., & Poyart, C. (2009) · Nature · doi:10.1038/nature07772 · Cited by 317
Mohammadi, T., van Dam, V., Sijbrandi, R., Vernet, T., Zapun, A., Bouhss, A., Diepeveen-de Bruin, M., Nguyen-Distèche, M., de Kruijff, B., & Breukink, E. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.61 · Cited by 315
Bister, B., Bischoff, D., Ströbele, M., Riedlinger, J., Reicke, A., Wolter, F., Bull, A. T., Zähner, H., Fiedler, H., & Süssmuth, R. D. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200353160 · Cited by 309
Structural Insight into the Transglycosylation Step of Bacterial Cell-Wall Biosynthesis
Lovering, A. L., de Castro, L. H., Lim, D., & Strynadka, N. C. J. (2007) · Science · doi:10.1126/science.1136611 · Cited by 306
SUICIDE SUBSTRATES, MECHANISM-BASED ENZYME INACTIVATORS: RECENT DEVELOPMENTS
Walsh, C. T. (1984) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.53.070184.002425 · Cited by 302
Self-citationWalsh, C. T., Chen, H., Keating, T. A., Hubbard, B. K., Losey, H. C., Luo, L., Marshall, C. G., Miller, D. A., & Patel, H. M. (2001) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00235-0 · Cited by 301
Self-citationBugg, T. D. H., & Walsh, C. T. (1992) · Natural Product Reports · doi:10.1039/np9920900199 · Cited by 300
Self-citationVancomycin Assembly: Nature′s Way
Hubbard, B. K., & Walsh, C. T. (2003) · ChemInform · doi:10.1002/chin.200322284 · Cited by 290
Self-citationCampbell, J., Singh, A. K., Santa Maria, J. P., Kim, Y., Brown, S., Swoboda, J. G., Mylonakis, E., Wilkinson, B. J., & Walker, S. (2011) · ACS Chemical Biology · doi:10.1021/cb100269f · Cited by 289
Frees, D., Savijoki, K., Varmanen, P., & Ingmer, H. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05598.x · Cited by 288
Enzymes in the D-alanine branch of bacterial cell wall peptidoglycan assembly
Walsh, C. T. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81624-1 · Cited by 287
Self-citationEpigenome manipulation as a pathway to new natural product scaffolds and their congeners
Cichewicz, R. H. (2010) · Nat. Prod. Rep. · doi:10.1039/b920860g · Cited by 282
Rustomjee, R., Diacon, A. H., Allen, J., Venter, A., Reddy, C., Patientia, R. F., Mthiyane, T. C. P., De Marez, T., van Heeswijk, R., Kerstens, R., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01204-07 · Cited by 278
Antibiotics in the clinical pipeline in 2011
Butler, M. S., & Cooper, M. A. (2011) · The Journal of Antibiotics · doi:10.1038/ja.2011.44 · Cited by 272
Discovery and Development of SQ109: A New Antitubercular Drug with a Novel Mechanism of Action
Sacksteder, K. A., Protopopova, M., Barry, C. E., Andries, K., & Nacy, C. A. (2012) · Future Microbiology · doi:10.2217/fmb.12.56 · Cited by 269
Daptomycin: mechanisms of action and resistance, and biosynthetic engineering
Baltz, R. H. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.02.031 · Cited by 267
The Impact of Bacterial Genomics on Natural Product Research
Bode, H. B., & Müller, R. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200501080 · Cited by 253
Transport of lipopolysaccharide across the cell envelope: the long road of discovery
Ruiz, N., Kahne, D., & Silhavy, T. J. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2184 · Cited by 249
Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitors
Coleman, K. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.07.026 · Cited by 241
Restoring Methicillin-Resistant Staphylococcus aureus Susceptibility to β-Lactam Antibiotics
Tan, C. M., Therien, A. G., Lu, J., Lee, S. H., Caron, A., Gill, C. J., Lebeau-Jacob, C., Benton-Perdomo, L., Monteiro, J. M., Pereira, P. M., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003592 · Cited by 241
Mining microbial genomes for new natural products and biosynthetic pathways
Challis, G. L. (2008) · Microbiology · doi:10.1099/mic.0.2008/018523-0 · Cited by 241
The RNA Polymerase “Switch Region” Is a Target for Inhibitors
Mukhopadhyay, J., Das, K., Ismail, S., Koppstein, D., Jang, M., Hudson, B., Sarafianos, S., Tuske, S., Patel, J., Jansen, R., et al. (2008) · Cell · doi:10.1016/j.cell.2008.09.033 · Cited by 240
Genome Mining for Novel Natural Product Discovery
Challis, G. L. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm700948z · Cited by 231
Vancomycin Resistance: Structure of D-Alanine:D-Alanine Ligase at 2.3 Å Resolution
Fan, C., Moews, P. C., Walsh, C. T., & Knox, J. R. (1994) · Science · doi:10.1126/science.7939684 · Cited by 226
Self-citationStructures of ClpP in complex with acyldepsipeptide antibiotics reveal its activation mechanism
Lee, B.-G., Park, E. Y., Lee, K.-E., Jeon, H., Sung, K. H., Paulsen, H., Rübsamen-Schaeff, H., Brötz-Oesterhelt, H., & Song, H. K. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1787 · Cited by 226
Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis
Neres, J., Pojer, F., Molteni, E., Chiarelli, L. R., Dhar, N., Boy-Röttger, S., Buroni, S., Fullam, E., Degiacomi, G., Lucarelli, A. P., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004395 · Cited by 222
Haagsma, A. C., Abdillahi-Ibrahim, R., Wagner, M. J., Krab, K., Vergauwen, K., Guillemont, J., Andries, K., Lill, H., Koul, A., & Bald, D. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01393-08 · Cited by 221
Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors
Batt, S. M., Jabeen, T., Bhowruth, V., Quill, L., Lund, P. A., Eggeling, L., Alderwick, L. J., Fütterer, K., & Besra, G. S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205735109 · Cited by 218
Trefzer, C., Rengifo-Gonzalez, M., Hinner, M. J., Schneider, P., Makarov, V., Cole, S. T., & Johnsson, K. (2010) · Journal of the American Chemical Society · doi:10.1021/ja106357w · Cited by 215
Uncultured microorganisms as a source of secondary metabolites
Lewis, K., Epstein, S., D'Onofrio, A., & Ling, L. L. (2010) · The Journal of Antibiotics · doi:10.1038/ja.2010.87 · Cited by 215
Brown, E. D., Vivas, E. I., Walsh, C. T., & Kolter, R. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.14.4194-4197.1995 · Cited by 212
Self-citationThe Chemical Versatility of Natural-Product Assembly Lines
Walsh, C. T. (2008) · Accounts of Chemical Research · doi:10.1021/ar7000414 · Cited by 211
Self-citationEmergence of Daptomycin Resistance in Enterococcus faecium during Daptomycin Therapy
Sabol, K., Patterson, J. E., Lewis, J. S., Owens, A., Cadena, J., & Jorgensen, J. H. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1664-1665.2005 · Cited by 209
Chng, S.-S., Ruiz, N., Chimalakonda, G., Silhavy, T. J., & Kahne, D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912872107 · Cited by 209
Daptomycin, a Bacterial Lipopeptide Synthesized by a Nonribosomal Machinery
Robbel, L., & Marahiel, M. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.128181 · Cited by 206
Jenner, L., Starosta, A. L., Terry, D. S., Mikolajka, A., Filonava, L., Yusupov, M., Blanchard, S. C., Wilson, D. N., & Yusupova, G. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216691110 · Cited by 204
Discovery of FabH/FabF Inhibitors from Natural Products
Young, K., Jayasuriya, H., Ondeyka, J. G., Herath, K., Zhang, C., Kodali, S., Galgoci, A., Painter, R., Brown-Driver, V., Yamamoto, R., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.519-526.2006 · Cited by 202
Tuske, S., Sarafianos, S. G., Wang, X., Hudson, B., Sineva, E., Mukhopadhyay, J., Birktoft, J. J., Leroy, O., Ismail, S., Clark, A. D., et al. (2005) · Cell · doi:10.1016/j.cell.2005.07.017 · Cited by 198
Vancomycin Resistance: Decoding the Molecular Logic
Walsh, C. T. (1993) · Science · doi:10.1126/science.8392747 · Cited by 194
Self-citationAntibiotic acyldepsipeptides activate ClpP peptidase to degrade the cell division protein FtsZ
Sass, P., Josten, M., Famulla, K., Schiffer, G., Sahl, H.-G., Hamoen, L., & Brötz-Oesterhelt, H. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110385108 · Cited by 194
Kim, D. H., Lees, W. J., Kempsell, K. E., Lane, W. S., Duncan, K., & Walsh, C. T. (1996) · Biochemistry · doi:10.1021/bi952937w · Cited by 192
Self-citationCytoplasmic ATP Hydrolysis Powers Transport of Lipopolysaccharide Across the Periplasm in E. coli
Okuda, S., Freinkman, E., & Kahne, D. (2012) · Science · doi:10.1126/science.1228984 · Cited by 188
Total biosynthesis: in vitro reconstitution of polyketide and nonribosomal peptide pathways
Sattely, E. S., Fischbach, M. A., & Walsh, C. T. (2008) · Natural Product Reports · doi:10.1039/b801747f · Cited by 186
Self-citationAndreu, J. M., Schaffner-Barbero, C., Huecas, S., Alonso, D., Lopez-Rodriguez, M. L., Ruiz-Avila, L. B., Núñez-Ramírez, R., Llorca, O., & Martín-Galiano, A. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.094722 · Cited by 184
Freinkman, E., Chng, S.-S., & Kahne, D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015617108 · Cited by 182
Tuberculosis: The drug development pipeline at a glance
Villemagne, B., Crauste, C., Flipo, M., Baulard, A. R., Déprez, B., & Willand, N. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.02.033 · Cited by 172
Phillips, J. W., Goetz, M. A., Smith, S. K., Zink, D. L., Polishook, J., Onishi, R., Salowe, S., Wiltsie, J., Allocco, J., Sigmund, J., et al. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.06.011 · Cited by 168
Crystal structure of the membrane-bound bifunctional transglycosylase PBP1b from Escherichia coli
Sung, M.-T., Lai, Y.-T., Huang, C.-Y., Chou, L.-Y., Shih, H.-W., Cheng, W.-C., Wong, C.-H., & Ma, C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904030106 · Cited by 168
Lienhardt, C., Raviglione, M., Spigelman, M., Hafner, R., Jaramillo, E., Hoelscher, M., Zumla, A., & Gheuens, J. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis034 · Cited by 167
Approval of Novel TB Drug Celebrated—With Restraint
Cohen, J. (2013) · Science · doi:10.1126/science.339.6116.130 · Cited by 166
Li, D. H. S., Chung, Y. S., Gloyd, M., Joseph, E., Ghirlando, R., Wright, G. D., Cheng, Y.-Q., Maurizi, M. R., Guarné, A., & Ortega, J. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.07.008 · Cited by 164
Moenomycin family antibiotics: chemical synthesis, biosynthesis, and biological activity
Ostash, B. O., & Walker, S. (2010) · Natural Product Reports · doi:10.1039/c001461n · Cited by 161
Yuan, Y., Barrett, D., Zhang, Y., Kahne, D., Sliz, P., & Walker, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701160104 · Cited by 158
Suicide substrates for the alanine racemase of Escherichia coli B
Wang, E., & Walsh, C. T. (1978) · Biochemistry · doi:10.1021/bi00600a028 · Cited by 156
Self-citationSimunović, V., Zapp, J., Rachid, S., Krug, D., Meiser, P., & Müller, R. (2006) · ChemBioChem · doi:10.1002/cbic.200600075 · Cited by 156
Characterization of the Polymyxin B Resistome of Pseudomonas aeruginosa
Fernández, L., Alvarez‐Ortega, C., Wiegand, I., Olivares‐Pacheco, J., Kocíncová, D., Lam, J. S., Martínez, J. L., & Hancock, R. E. W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01583-12 · Cited by 155
Healy, V. L., Lessard, I. A. D., Roper, D. I., Knox, J. R., & Walsh, C. T. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00116-2 · Cited by 150
Self-citationProteins Required for Lipopolysaccharide Assembly in Escherichia coli Form a Transenvelope Complex
Chng, S., Gronenberg, L. S., & Kahne, D. E. (2010) · Biochemistry · doi:10.1021/bi100493e · Cited by 148
Structural, functional, and genetic analysis of sorangicin inhibition of bacterial RNA polymerase
Campbell, E. A., Pavlova, O. A., Zenkin, N., Leon, F., Irschik, H., Jansen, R., Severinov, K., & Darst, S. A. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600499 · Cited by 147
Xie, J. H., Pierce, J. G., James, R. C., Okano, A., & Boger, D. L. (2011) · Journal of the American Chemical Society · doi:10.1021/ja207142h · Cited by 140
Discovery of torezolid as a novel 5-hydroxymethyl-oxazolidinone antibacterial agent
Im, W. B., Choi, S. H., Park, J., Choi, S. H., Finn, J., & Yoon, S. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.01.014 · Cited by 139
Organic synthesis toward small-molecule probes and drugs
Schreiber, S. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103205108 · Cited by 137
Venugopal, A. A., & Johnson, S. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir830 · Cited by 135
The discovery of antibacterial agents using diversity-oriented synthesis
Galloway, W. R. J. D., Bender, A., Welch, M., & Spring, D. R. (2009) · Chemical Communications · doi:10.1039/b816852k · Cited by 133
Regulated Assembly of the Transenvelope Protein Complex Required for Lipopolysaccharide Export
Freinkman, E., Okuda, S., Ruiz, N., & Kahne, D. E. (2012) · Biochemistry · doi:10.1021/bi300592c · Cited by 131
Quinupristin/dalfopristin: A therapeutic review
Allington, D. R., & Rivey, M. P. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80028-x · Cited by 129
Chimalakonda, G., Ruiz, N., Chng, S., Garner, R. A., Kahne, D. E., & Silhavy, T. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019089108 · Cited by 129
Nonconsecutive disulfide bond formation in an essential integral outer membrane protein
Ruiz, N., Chng, S., Hiniker, A. O., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007319107 · Cited by 129
Drug Discovery and Development
(2006) · Chemical & Engineering News · doi:10.1021/cen-v084n039.p020 · Cited by 128
Metagenomic approaches to natural products from free-living and symbiotic organisms
Brady, S. F., Simmons, L., Kim, J. H., & Schmidt, E. W. (2009) · Natural Product Reports · doi:10.1039/b817078a · Cited by 128
Bugs, drugs and chemical genomics
Roemer, T., DAVIES, J. E., Giaever, G. N., & Nislow, C. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.744 · Cited by 127
Inhibition of prolipoprotein signal peptidase by globomycin.
Dev, I. K., Harvey, R. J., & Ray, P. H. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)88911-6 · Cited by 123
Villa, R., Martorana, A. M., Okuda, S., Gourlay, L. J., Nardini, M., Sperandeo, P., Dehò, G., Bolognesi, M., Kahne, D. E., & Polissi, A. (2013) · Journal of Bacteriology · doi:10.1128/jb.02057-12 · Cited by 122
Huber, J. L., Donald, R. G. K., Lee, S. H., Jarantow, L. W., Salvatore, M. J., Meng, X., Painter, R. E., Onishi, R., Occi, J., Dorso, K., et al. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.05.012 · Cited by 121
Structures of RNA polymerase–antibiotic complexes
Ho, M. X., Hudson, B. P., Das, K., Arnold, E., & Ebright, R. H. (2009) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2009.10.010 · Cited by 118
Redesign of Glycopeptide Antibiotics: Back to the Future
James, R. C., Pierce, J. G., Okano, A., Xie, J. H., & Boger, D. L. (2012) · ACS Chemical Biology · doi:10.1021/cb300007j · Cited by 118
Discovery of LFF571: An Investigational Agent for Clostridium difficile Infection
LaMarche, M. J., Leeds, J. A., Amaral, A., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201685h · Cited by 116
Crystal Structures of the Complexes between Vancomycin and Cell-Wall Precursor Analogs
Nitanai, Y., Kikuchi, T., Kakoi, K., Hanamaki, S., Fujisawa, I., & Aoki, K. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.10.026 · Cited by 115
Prokocimer, P., Bien, P. A., Surber, J., Mehra, P., DeAnda, C., Bulitta, J. B., & Corey, G. R. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00076-10 · Cited by 115
Barb, A. W., Jiang, L., Raetz, C. R. H., & Zhou, P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709412104 · Cited by 111
Udwary, D., Gontang, E. A., Jones, A. C., Jones, C. S., Schultz, A. W., Winter, J. M., Yang, J. Y., Beauchemin, N., Capson, T. L., Clark, B. R., et al. (2011) · Applied and Environmental Microbiology · doi:10.1128/aem.00038-11 · Cited by 109
Mochalkin, I., Miller, J. R., Narasimhan, L. S., Thanabal, V., Erdman, P. E., Cox, P. B., Prasad, J. V. N. V., Lightle, S., Huband, M. D., & Stover, C. K. (2009) · ACS Chemical Biology · doi:10.1021/cb9000102 · Cited by 108
Pratt, W. B., & Fekety, F. R. (1986) · Cited by 107
Disulfide Rearrangement Triggered by Translocon Assembly Controls Lipopolysaccharide Export
Chng, S., Xue, M., Garner, R. A., Kadokura, H., Boyd, D. H., Beckwith, J. R., & Kahne, D. E. (2012) · Science · doi:10.1126/science.1227215 · Cited by 107
Species-Specific and Inhibitor-Dependent Conformations of LpxC: Implications for Antibiotic Design
Lee, C.-J., Liang, X., Chen, X., Zeng, D., Joo, S. H., Chung, H. S., Barb, A. W., Swanson, S. M., Nicholas, R. A., Li, Y., et al. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.11.011 · Cited by 105
Structural Basis of the Action of Pulvomycin and GE2270 A on Elongation Factor Tu ,
Parmeggiani, A., Krab, I. M., Okamura, S., Nielsen, R. C., Nyborg, J., & Nissen, P. (2006) · Biochemistry · doi:10.1021/bi0525122 · Cited by 100
Myxobacterium-Produced Antibiotic TA (Myxovirescin) Inhibits Type II Signal Peptidase
Xiao, Y., Gerth, K., Müller, R., & Wall, D. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06148-11 · Cited by 97
Donald, R. G. K., Skwish, S., Forsyth, A., Anderson, J. W., Zhong, T., Burns, C. M., Lee, S., Meng, X., LoCastro, L., Jarantow, L. W., et al. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.07.004 · Cited by 97
Kallifidas, D., Kang, H., & Brady, S. F. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3093828 · Cited by 96
A genomic approach to the cryptic secondary metabolome of the anaerobic world
Letzel, A., Pidot, S. J., & Hertweck, C. (2012) · Natural Product Reports · doi:10.1039/c2np20103h · Cited by 95
Benson, T. E., Walsh, C. T., & Hogle, J. M. (1996) · Structure · doi:10.1016/s0969-2126(96)00008-1 · Cited by 93
Self-citationAn enzyme–substrate complex involved in bacterial cell wall biosynthesis
Benson, T. E., Filman, D. J., Walsh, C. T., & Hogle, J. M. (1995) · Nature Structural Biology · doi:10.1038/nsb0895-644 · Cited by 88
Self-citationLiu, W.-T., Kersten, R. D., Yang, Y., Moore, B. S., & Dorrestein, P. C. (2011) · Journal of the American Chemical Society · doi:10.1021/ja2040877 · Cited by 86
From natural product to marketed drug: the tiacumicin odyssey
Erb, W., & Zhu, J. (2012) · Natural Product Reports · doi:10.1039/c2np20080e · Cited by 86
The Total Synthesis of Moenomycin A
Taylor, J. G., Li, X., Oberthür, M., Zhu, W., & Kahne, D. E. (2006) · Journal of the American Chemical Society · doi:10.1021/ja065907x · Cited by 85
Brown, S. D., & Traczewski, M. M. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01569-09 · Cited by 84
Scholar, E. M., & Pratt, W. B. (2000) · doi:10.1093/oso/9780195125283.001.0001 · Cited by 81
Anderson, D. E., Kim, M. B., Moore, J. T., O’Brien, T. E., Sorto, N. A., Grove, C. I., Lackner, L. L., Ames, J. B., & Shaw, J. T. (2012) · ACS Chemical Biology · doi:10.1021/cb300340j · Cited by 80
Robinson, J. A., Shankaramma, S. C., Jetter, P., Kienzl, U., Schwendener, R. A., Vrijbloed, J. W., & Obrecht, D. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.01.009 · Cited by 79
New Syntheses of E7389 C14−C35 and Halichondrin C14−C38 Building Blocks: Double-Inversion Approach
Kim, D., Dong, C., Kim, J. T., Guo, H., Huang, J. C., Tiseni, P. S., & Kishi, Y. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9058475 · Cited by 78
Anderson, M. S., Robertson, A. D., Macher, I., & Raetz, C. R. H. (1988) · Biochemistry · doi:10.1021/bi00406a017 · Cited by 78
Antagonism of Chemical Genetic Interaction Networks Resensitize MRSA to β-Lactam Antibiotics
Lee, S. H., Jarantow, L. W., Wang, H., Sillaots, S., Cheng, H. S., Meredith, T. C., Thompson, J. R., & Roemer, T. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.08.015 · Cited by 78
Broadening the Spectrum of β-Lactam Antibiotics through Inhibition of Signal Peptidase Type I
Therien, A. G., Huber, J. L., Wilson, K. E., Beaulieu, P., Caron, A., Claveau, D., Deschamps, K., Donald, R. G. K., Galgoci, A. M., Gallant, M., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00726-12 · Cited by 76
Rχ-01, a New Family of Oxazolidinones That Overcome Ribosome-Based Linezolid Resistance
Skripkin, E. A., McConnell, T., DeVito, J., Lawrence, L. E., Ippolito, J. A., Duffy, E. M., Sutcliffe, J. A., & Franceschi, F. J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01193-07 · Cited by 76
Complete Characterization of the Seventeen Step Moenomycin Biosynthetic Pathway
Ostash, B. O., Doud, E. H., Lin, C., Ostash, I., Perlstein, D. L., Fuse, S., Wolpert, M., Kahne, D. E., & Walker, S. (2009) · Biochemistry · doi:10.1021/bi901018q · Cited by 75
Calderone, C. T., Iwig, D. F., Dorrestein, P. C., Kelleher, N. L., & Walsh, C. T. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.06.008 · Cited by 74
Self-citationActive-Site Mapping of Escherichia coli D-Ala-D-Ala Ligase by Structure-Based Mutagenesis
Shi, Y., & Walsh, C. T. (1995) · Biochemistry · doi:10.1021/bi00009a005 · Cited by 70
Self-citationStructural basis for transcription inhibition by tagetitoxin
Vassylyev, D. G., Svetlov, V. V., Vassylyeva, M. N., Perederina, A. A., Igarashi, N., Matsugaki, N., Wakatsuki, S., & Artsimovitch, I. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1015 · Cited by 70
Gentry, D. R., McCloskey, L., Gwynn, M. N., Rittenhouse, S. F., Scangarella, N., Shawar, R. M., & Holmes, D. J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00915-08 · Cited by 70
Shankaramma, S. C., Athanassiou, Z., Zerbe, O., Moehle, K., Mouton, C., Bernardini, F., Vrijbloed, J. W., Obrecht, D., & Robinson, J. A. (2002) · ChemBioChem · Cited by 69
What counters antibiotic resistance in nature?
Chait, R., Vetsigian, K., & Kishony, R. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.745 · Cited by 67
Wang, E. A., & Walsh, C. T. (1981) · Biochemistry · doi:10.1021/bi00529a032 · Cited by 65
Self-citationSkarzynski, T. J., Kim, D. H., Lees, W. J., Walsh, C. T., & Duncan, K. (1998) · Biochemistry · doi:10.1021/bi9722608 · Cited by 64
Self-citationSynthesis and Antibacterial Activity of Pentacyclines: A Novel Class of Tetracycline Analogs
Sun, C., Hunt, D. K., Clark, R. B., Lofland, D., O’Brien, W. J., Plamondon, L., & Xiao, X.-Y. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1015395 · Cited by 64
Mechanism of Action of the Arylomycin Antibiotics and Effects of Signal Peptidase I Inhibition
Smith, P. A., & Romesberg, F. E. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00785-12 · Cited by 62
Liu, J., Luo, C., Smith, P. A., Chin, J. K., Page, M. G. P., Paetzel, M., & Romesberg, F. E. (2011) · Journal of the American Chemical Society · doi:10.1021/ja207318n · Cited by 58
Benson, T. E., Walsh, C. T., & Hogle, J. M. (1997) · Biochemistry · doi:10.1021/bi962221g · Cited by 58
Self-citationATP-Binding Site of Bacterial Enzymes as a Target for Antibacterial Drug Design
Škedelj, V., Tomašič, T., Mašič, L. P., & Zega, A. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101121s · Cited by 57
Discovery of Selective and Potent Inhibitors of Gram-Positive Bacterial Thymidylate Kinase (TMK)
Martínez-Botella, G., Breen, J. N., Duffy, J. E., Dumas, J., Bolin, G., Gowers, I. K., Green, O. M., Guler, S. Y., Hentemann, M. F., Hernandez‐Juan, F. A., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3011806 · Cited by 54
Choi, J. Y., Plummer, M. S., Starr, J. T., Desbonnet, C. R., Soutter, H. H., Chang, J. S., Miller, J. R., Dillman, K. S., Miller, A. A., & Roush, W. R. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201349f · Cited by 54
Corey, G. R., Stryjewski, M. E., Weyenberg, W., Yasothan, U., & Kirkpatrick, P. N. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd3051 · Cited by 53
Tuning the Moenomycin Pharmacophore To Enable Discovery of Bacterial Cell Wall Synthesis Inhibitors
Gampe, C. M., Tsukamoto, H., Doud, E. H., Walker, S., & Kahne, D. E. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4000933 · Cited by 51
Lemaire, S., Kosowska-Shick, K., Appelbaum, P. C., Verween, G., Tulkens, P. M., & Françoise Van Bambeke, A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01724-09 · Cited by 51
Structure–activity relationships of globomycin analogues as antibiotics
Kiho, T., Nakayama, M., Yasuda, K., Miyakoshi, S., Inukai, M., & Kogen, H. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.10.055 · Cited by 50
Initial Efforts toward the Optimization of Arylomycins for Antibiotic Activity
Roberts, T. C., Schallenberger, M. A., Liu, J., Smith, P. A., & Romesberg, F. E. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1016126 · Cited by 49
A Chemical Proteomics Approach to Profiling the ATP-binding Proteome of Mycobacterium tuberculosis
Wolfe, L. M., Usha, V., Idicula‐Thomas, S., Schürer, S. C., Wennerberg, K., Reynolds, R. C., Besra, G. S., & Dobos, K. M. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.025635 · Cited by 47
Keating, T. A., Newman, J. V., Olivier, N. B., Otterson, L. G., Andrews, B. M., Boriack‐Sjodin, P. A., Breen, J. N., Doig, P. C., Dumas, J., Gangl, E. T., et al. (2012) · ACS Chemical Biology · doi:10.1021/cb300316n · Cited by 44
Milewski, S., Andruszkiewicz, R., Kasprzak, L., et al. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.1.36 · Cited by 43
Solid Phase Synthesis of Globomycin and SF-1902 A5
Sarabia, F., Chammaa, S., & García‐Ruiz, C. (2011) · The Journal of Organic Chemistry · doi:10.1021/jo1025145 · Cited by 36
Cited by
Antibiotics: past, present and future
Hutchings, M. I., Truman, A. W., & Wilkinson, B. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.10.008 · Cited by 2,370
The global threat of antimicrobial resistance: science for intervention.
Roca, I., Akova, M., Baquero, F., Carlet, J., Cavaleri, M., Coenen, S., Cohen, J., Findlay, D., Gyssens, I., Heure, O. E., et al. (2015) · New Microbes and New Infections · doi:10.1016/j.nmni.2015.02.007 · Cited by 1,106
Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches
Roemer, T., & Krysan, D. J. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019703 · Cited by 593
Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It
Zgurskaya, H. I., López, C. A., & Gnanakaran, S. (2015) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00097 · Cited by 580
Next-generation approaches to understand and combat the antibiotic resistome
Crofts, T. S., Gasparrini, A. J., & Dantas, G. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.28 · Cited by 535
Metadata
- Authors
- Walsh, C. T., & Wencewicz, T. A.
- Venue
- The Journal of Antibiotics
- Published
- 2013-06-12
- Volume
- 67
- Issue
- 1
- Pages
- 7-22
- ISSN
- 0021-8820 (ISSN-L)
- 1881-1469
- OpenAlex
- W2010856072
- Cited by
- 372
- References
- 180
- FWCI
- 19.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.